Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Bone Marrow Derived Mesenchymal Stem Cells (MSCs) for the Treatment of Medically Refractory Pouchitis

NCT05578508 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT05578508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05578508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Bone Marrow Derived Mesenchymal Stem Cells (MSCs) for the Treatment of Medically Refractory Pouchitis
Lead sponsor
The Cleveland Clinic
Phase
Phase 1
Overall status
Withdrawn
Start date
April 30, 2022
Completion date
February 29, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, inflammatory bowel diseases, pouch, ileal, pouchitis, ulcerative colitis chronic